Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Lexeo Therapeutics (LXEO) Equity Ratio (2022 - 2026)

Lexeo Therapeutics' Equity Ratio history spans 2 years, with the latest figure at 0.81 for Q4 2023.

  • On a quarterly basis, Equity Ratio rose 169.79% to 0.81 in Q4 2023 year-over-year; TTM through Dec 2023 was 0.81, a 169.79% increase, with the full-year FY2023 number at 0.81, up 169.79% from a year prior.
  • Equity Ratio hit 0.81 in Q4 2023 for Lexeo Therapeutics, up from 2.98 in the prior quarter.
  • Over the last five years, Equity Ratio for LXEO hit a ceiling of 0.81 in Q4 2023 and a floor of 2.98 in Q3 2023.